PENICILLIN G SODIUM FOR INJECTION, USP 5000000 UNIT
PENICILLIN G (PENICILLIN G SODIUM) : 5000000 UNIT · DIN 02220288 · FRESENIUS KABI CANADA LTD
Health Canada status: MARKETED
What is PENICILLIN G SODIUM FOR INJECTION, USP?
PENICILLIN G SODIUM FOR INJECTION, USP 5000000 UNIT contains PENICILLIN G (PENICILLIN G SODIUM) : 5000000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02220288, held by FRESENIUS KABI CANADA LTD, supplied as POWDER FOR SOLUTION for INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 26-Jun-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PENICILLIN G SODIUM FOR INJECTION, USP used for?
Penicillin G Sodium for Injection, USP is indicated in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillinemia is required. Therapy should be guided by bacteriological studies, including susceptibility tests and by clinical response. The following infections will usually respond to adequate dosage: Streptococcal infections, Pneumococcal Infections, Staphylococcal infections - Penicillin G-susceptible; Anthrax; Actinomycosis; Clostridial infections (including tetanus); Diphtheria (to prevent the carrier state); Erysipeloid endocarditis (Erysipelothrix insidiosa); Vincent's gingivitis and pharyngitis (fusospirochetosis); Severe infections of the oropharynx and lower respiratory tract and genital area infections due to F. fusiformisans spirochetes; Gram negative bacillary infections (bacteremias); Listeria infections (L. monocytogenes); Meningitis and endocarditis; Pasteurella infections (P. multocida); Bacteremia and meningitis; Rat bite fever (S. minus or S. moniliformis); Gonorrheal endocarditis and arthritis (N. gonorrhoeae); Syphilis (T. pallidum) including congenital syphilis; Meningococcic meningitis. It is also used for the prevention of bacterial endocarditis where patients are unable to take oral antibiotics.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02220288 |
|---|---|
| Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Generic / active ingredient | PENICILLIN G (PENICILLIN G SODIUM) : 5000000 UNIT |
| Manufacturer | FRESENIUS KABI CANADA LTD |
| Strength | 5000000 UNIT |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | J01CE01 BENZYLPENICILLIN |
| AHFS class | 08:12.16.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Jun-2015 |
| Original market date | 1997-01-23 00:00:00 |
How is it stored and handled?
Store dry powder at a controlled room temperature (between 15 °C and 25 °C). Store reconstituted solution at a controlled room temperature (between 15 °C and 25 °C) for up to 24 hours or under refrigeration (between 2 °C and 8 °C) for up to 5 days.
How is it supplied?
1 million, 5 million and 10 million units per vial
What can be used instead?
Other Canadian products sharing ATC code J01CE01 BENZYLPENICILLIN. 3 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PENICILLIN G SODIUM FOR INJECTION, USP | 1000000 UNIT | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02220261 |
| PENICILLIN G SODIUM FOR INJECTION, USP | 10000000 UNIT | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02220296 |
| CRYSTAPEN | 5000000 UNIT | POWDER FOR SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02060094 |
| CRYSTAPEN 1 000 000 IU PWS | 1000000 UNIT | POWDER FOR SOLUTION | BIONICHE PHARMA (CANADA) LTD | CANCELLED POST MARKET | DIN 02060086 |
| CRYSTAPEN 10000000 IU PWS | 10000000 UNIT | POWDER FOR SOLUTION | BIONICHE PHARMA (CANADA) LTD | CANCELLED POST MARKET | DIN 02060108 |
| CRYSTAPEN 10M I.U. | 10000000 UNIT | POWDER FOR SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED PRE MARKET | DIN 02300508 |
| CRYSTAPEN 1M I.U. | 1000000 UNIT | POWDER FOR SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED PRE MARKET | DIN 02300478 |
| CRYSTAPEN 5M I.U. | 5000000 UNIT | POWDER FOR SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02300443 |
| MEGACILLIN 500 TABLETS | Strength | Tablet | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. 16711 Trans Canada Highway Kirkland Quebec Canada H9H 3L1 | CANCELLED POST MARKET | DIN 00107484 |
| NOVO-PEN G 500 | 500000 UNIT | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00151432 |
Who else supplies BENZYLPENICILLIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BENZYLPENICILLIN appears in 32 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.